GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Days Sales Outstanding

China National Accord Medicines (SZSE:000028) Days Sales Outstanding : 98.35 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines Days Sales Outstanding?

China National Accord Medicines's average Accounts Receivable for the three months ended in Mar. 2024 was ¥20,575 Mil. China National Accord Medicines's Revenue for the three months ended in Mar. 2024 was ¥19,090 Mil. Hence, China National Accord Medicines's Days Sales Outstanding for the three months ended in Mar. 2024 was 98.35.

The historical rank and industry rank for China National Accord Medicines's Days Sales Outstanding or its related term are showing as below:

SZSE:000028' s Days Sales Outstanding Range Over the Past 10 Years
Min: 67.42   Med: 72.76   Max: 101.58
Current: 101.58

During the past 13 years, China National Accord Medicines's highest Days Sales Outstanding was 101.58. The lowest was 67.42. And the median was 72.76.

SZSE:000028's Days Sales Outstanding is ranked worse than
71.43% of 98 companies
in the Medical Distribution industry
Industry Median: 72.705 vs SZSE:000028: 101.58

China National Accord Medicines's Days Sales Outstanding increased from Mar. 2023 (80.74) to Mar. 2024 (98.35).


China National Accord Medicines Days Sales Outstanding Historical Data

The historical data trend for China National Accord Medicines's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Days Sales Outstanding Chart

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.32 75.00 79.46 73.87 77.19

China National Accord Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.74 95.48 113.17 99.92 98.35

Competitive Comparison of China National Accord Medicines's Days Sales Outstanding

For the Medical Distribution subindustry, China National Accord Medicines's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines's Days Sales Outstanding Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Days Sales Outstanding falls into.



China National Accord Medicines Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

China National Accord Medicines's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (13764.776 + 18160.331) / 2 ) / 75477.485*365
=15962.5535 / 75477.485*365
=77.19

China National Accord Medicines's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (18160.331 + 22990.158) / 2 ) / 19090.481*365 / 4
=20575.2445 / 19090.481*365 / 4
=98.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China National Accord Medicines  (SZSE:000028) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


China National Accord Medicines Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
Executives
Su Wei Wei Independent director
Chen Chang Bing Secretary Dong
Peng Juan Director
Fu Ming Zhong Director

China National Accord Medicines (SZSE:000028) Headlines

No Headlines